spacer
home > epc > spring 2002 > stem cells - the clinician's 'philosopher's stone'
PUBLICATIONS
European Pharmaceutical Contractor

Stem Cells - The Clinician's 'Philosopher's Stone'

2001 saw an explosion of interest in stem cells, both in scientific literature and the popular press. Much of this revolved around emotive issues related to manipulation of the pluripotentiality (ability to produce many cell types) of either embryonic or adult stem cells. However, there is still a poor appreciation among the commercial scientific community of the importance of adult tissue stem cells in normal tissue homeostasis and how drugs affect their behaviour. A thorough preclinical evaluation of the effects of potential new drugs on these adult tissue stem cells can reveal mechanisms of action that can significantly improve the efficacy of clinical trials and reduce late stage drug failure.

The Definition and Importance of Stem Cells in Tissue Homeostasis

The fertilised zygote is the ultimate totipotential (capable of making all cell types) stem cell, capable of forming all the differentiated cells and tissues of the body according to strict temporal and spatial controls. The factors that regulate these processes during development are only beginning to be understood. The early divisions of the zygote during development produce further totipotent stem cells and - at least up to the blastocyst stage - cells of the inner cell mass can be isolated, grown and expanded in culture as embryonic stem (ES) cells.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Professor Christopher Potten, Founder of EpiStem Ltd

Professor Christopher Potten is an Emeritus Professor of the UK Cancer Research Campaign, Professor of Stem Cell Biology at Manchester University and a Founder of EpiStem Ltd, a specialist preclinical CRO.

He is a world expert in epithelial stem cell biology and apoptosis, publishing around 400 papers in these areas, and over recent years has assisted many pharmaceutical companies in evaluating their novel anti-cancer and mucositis therapies.

spacer
Professor Christopher Potten
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement